COVID-19 rollout resumes in Olongapo City; 600 more get jabs | Inquirer News

COVID-19 rollout resumes in Olongapo City; 600 more get jabs

Olongapo-City-06162021

Olongapo City residents wait for their turn to be vaccinated against COVID-19 during a rollout at the SMX Convention Center in SM Central Olongapo. (Photo courtesy of Olongapo City Information Office)

OLONGAPO CITY––The city government continued vaccinating Wednesday against COVID-19 after receiving a new supply from the national government.

About 600 doses of Sinovac and AstraZeneca were expected to be administered during the first of two days of rollout at the SMX Convention Center in SM Central Olongapo.

ADVERTISEMENT

The vaccines are for older citizens and residents with comorbidities.

FEATURED STORIES

At least 290 doses of the vaccine are for priority residents receiving the first dose of Sinovac. The remaining supply is for residents receiving the second shots of Sinovac and AstraZeneca.

The vaccination rollout was stopped due to the limited supply of vaccines.

More residents on the priority list would be inoculated Thursday.

The city had vaccinated over 13,000 residents.

It needs to inoculate 70 percent of its 233,000 population to achieve herd immunity. INQ

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo City

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.